Showing 1 – 8 of 8
Relevance | Newest | Oldest |
  • Low-Density Lipoprotein Cholesterol Level After a Stroke—Reducing It by Any Means

    Abstract Full Text
    ÁñÁ«ÊÓƵ Neurol. 2022; 79(4):329-330. 10.1001/jamaneurol.2021.5586
  • Noncontrast Computed Tomography vs Computed Tomography Perfusion or Magnetic Resonance Imaging Selection in Late Presentation of Stroke With Large-Vessel Occlusion

    Abstract Full Text
    open access is active quiz
    ÁñÁ«ÊÓƵ Neurol. 2021; 79(1):22-31. 10.1001/jamaneurol.2021.4082

    This cohort study compares the clinical outcomes of patients with stroke who presented 6 to 24 hours after symptom onset and were selected for mechanical thrombectomy by noncontrast computed tomography vs those selected by computed tomography perfusion or magnetic resonance imaging.

  • Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia

    Abstract Full Text
    free access is active quiz
    ÁñÁ«ÊÓƵ Neurol. 2021; 78(11):1314-1323. 10.1001/jamaneurol.2021.3619

    This cohort study describes the clinical characteristics and outcome of patients with cerebral venous sinus thrombosis after SARS-CoV-2 vaccination with and without thrombosis with thrombocytopenia syndrome.

  • Cerebral Microbleeds and Antithrombotic Treatments—Stop Worrying About Bleeding

    Abstract Full Text
    ÁñÁ«ÊÓƵ Neurol. 2020; 78(1):9-10. 10.1001/jamaneurol.2020.3847
  • Effect of In-Hospital Remote Ischemic Perconditioning on Brain Infarction Growth and Clinical Outcomes in Patients With Acute Ischemic Stroke: The RESCUE BRAIN Randomized Clinical Trial

    Abstract Full Text
    free access
    ÁñÁ«ÊÓƵ Neurol. 2020; 77(6):725-734. 10.1001/jamaneurol.2020.0326

    This randomized clinical trial examines whether in-hospital treatment with remote ischemic perconditioning that is administered within 6 hours of symptom onset, with or without reperfusion therapy, can reduce brain infarction volume growth in patients with acute ischemic stroke.

  • Is Hyperselection of Patients the Right Strategy?

    Abstract Full Text
    ÁñÁ«ÊÓƵ Neurol. 2019; 76(12):1426-1427. 10.1001/jamaneurol.2019.0213
  • Risk of Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis in Patients With Acute Ischemic Stroke and High Cerebral Microbleed Burden: A Meta-analysis

    Abstract Full Text
    free access
    ÁñÁ«ÊÓƵ Neurol. 2016; 73(6):675-683. 10.1001/jamaneurol.2016.0292

    This meta-analysis investigates the association of high cerebral microbleed burden with the risk of symptomatic intracerebral hemorrhage in patients with acute ischemic stroke treated with intravenous thrombolysis.

  • Long-term Follow-up of Acute Partial Transverse Myelitis

    Abstract Full Text
    free access
    Arch Neurol. 2012; 69(3):357-362. 10.1001/archneurol.2011.949